Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today that a peer-reviewed study conducted by researchers at Stanford University and published in ...

The intervention being tested is Efruxifermin, administered via subcutaneous injection. It is designed to improve liver health in patients with NASH/MASH by reducing liver fat and fibrosis. This ...

At Tateetra & Rathmore Farms in counties Louth and Meath, John Kingham runs one of the most impressive suckler operations in ...

The interventions being tested include risankizumab, ABBV-382, and lutikizumab. These drugs are administered either as subcutaneous injections or intravenous infusions, with the goal of reducing ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist, previously approved as IMCIVREE ® by the FDA, the EMA, and UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) for obesity due to ...

HAMPTON, NJ, USA I August 19, 2025 I Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported topline results from the Company’s ongoing Phase 2 study of ...

Learn more about whether Liquidia Corporation or Organon & Co. is a better investment based on AAII's A+ Investor grades, ...